ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
Go back to ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat| ORION MARINE GROUP, Inc. (NYSE: ORN) | Delayed: 9.27 -0.46 (4.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.73 | 52 Week High | $9.48 | |||
| Open | $9.68 | 52 Week Low | $3.25 | |||
| Day High | $9.70 | P/E | N/A | |||
| Day Low | $9.22 | EPS | $-0.01 | |||
| Volume | 312,695 | |||||
